These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10462253)
1. Immunity obtained by gene-gun inoculation of a rotavirus DNA vaccine to the abdominal epidermis or anorectal epithelium. Chen SC; Fynan EF; Greenberg HB; Herrmann JE Vaccine; 1999 Aug; 17(23-24):3171-6. PubMed ID: 10462253 [TBL] [Abstract][Full Text] [Related]
2. Protective immunity induced by rotavirus DNA vaccines. Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543 [TBL] [Abstract][Full Text] [Related]
3. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Choi AH; Knowlton DR; McNeal MM; Ward RL Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596 [TBL] [Abstract][Full Text] [Related]
4. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Choi AH; Basu M; Rae MN; McNeal MM; Ward RL Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437 [TBL] [Abstract][Full Text] [Related]
5. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. Chen SC; Jones DH; Fynan EF; Farrar GH; Clegg JC; Greenberg HB; Herrmann JE J Virol; 1998 Jul; 72(7):5757-61. PubMed ID: 9621034 [TBL] [Abstract][Full Text] [Related]
6. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection. Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027 [TBL] [Abstract][Full Text] [Related]
8. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant. Choi AH; McNeal MM; Flint JA; Basu M; Lycke NY; Clements JD; Bean JA; Davis HL; McCluskie MJ; VanCott JL; Ward RL Vaccine; 2002 Mar; 20(13-14):1733-40. PubMed ID: 11906760 [TBL] [Abstract][Full Text] [Related]
9. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499 [TBL] [Abstract][Full Text] [Related]
10. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies. García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697 [TBL] [Abstract][Full Text] [Related]
11. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. Feng N; Burns JW; Bracy L; Greenberg HB J Virol; 1994 Dec; 68(12):7766-73. PubMed ID: 7966566 [TBL] [Abstract][Full Text] [Related]
12. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. Aberle JH; Aberle SW; Allison SL; Stiasny K; Ecker M; Mandl CW; Berger R; Heinz FX J Immunol; 1999 Dec; 163(12):6756-61. PubMed ID: 10586074 [TBL] [Abstract][Full Text] [Related]
13. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice. Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization. Lopez-Guerrero DV; Arias N; Gutierrez-Xicotencatl L; Chihu-Amparan L; González A; Pedroza-Saavedra A; Rosas-Salgado G; Villegas-Garcia JC; Badillo-Godinez O; Fernandez G; Lopez S; Esquivel-Guadarrama F Vaccine; 2018 May; 36(22):3072-3078. PubMed ID: 28465094 [TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant. Siadat-Pajouh M; Cai L Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595 [TBL] [Abstract][Full Text] [Related]
16. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Jiang B; Estes MK; Barone C; Barniak V; O'Neal CM; Ottaiano A; Madore HP; Conner ME Vaccine; 1999 Feb; 17(7-8):1005-13. PubMed ID: 10067709 [TBL] [Abstract][Full Text] [Related]
17. Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4 Heinimäki S; Malm M; Vesikari T; Blazevic V Antiviral Res; 2018 Sep; 157():1-8. PubMed ID: 29935205 [TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization of mice with VP2 DNA of human rotavirus a induces cellular and humoral immunity. Pourasgari F; Ahmadian S; Hassan ZM; Mahdavi M; Salmanian AH; Sarbolouki MN; Pothier P Acta Virol; 2008; 52(4):225-9. PubMed ID: 19143478 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the immune responses in BALB/c mice following immunization with DNA-based and live attenuated vaccines delivered via different routes. Cai MS; Deng SX; Li ML Vaccine; 2013 Feb; 31(9):1353-6. PubMed ID: 22995858 [TBL] [Abstract][Full Text] [Related]
20. Protection against rotavirus infections by DNA vaccination. Herrmann JE; Chen SC; Fynan EF; Santoro JC; Greenberg HB; Wang S; Robinson HL J Infect Dis; 1996 Sep; 174 Suppl 1():S93-7. PubMed ID: 8752297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]